(Q51184839)

1 April 2018

title

Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus (English)

1 reference

1 April 2018

0 references

7

Michael Kiehntopf

1 reference

1 April 2018

author name string

Thomas Neumann

1

1 reference

1 April 2018

Lorenz C Hofbauer

2

1 reference

1 April 2018

Martina Rauner

3

1 reference

1 April 2018

Sabine Lodes

4

1 reference

1 April 2018

Bettina Kästner

5

1 reference

1 April 2018

Sybille Franke

6

1 reference

1 April 2018

Thomas Lehmann

8

1 reference

1 April 2018

Ulrich A Müller

9

1 reference

1 April 2018

Gunter Wolf

10

1 reference

1 April 2018

Christine Hamann

11

1 reference

1 April 2018

Alexander Sämann

12

1 reference

1 April 2018

publication date

12 December 2013

1 reference

1 April 2018

published in

Clinical Endocrinology

1 reference

1 April 2018

volume

80

1 reference

1 April 2018

issue

5

1 reference

1 April 2018

page(s)

649-655

1 reference

1 April 2018

Bone metabolic abnormalities associated with well-controlled type 1 diabetes (IDDM) in young adult women: a disease complication often ignored or neglected.

cites work

1 reference

Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes

21 January 2018

1 reference

Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis

21 January 2018

1 reference

Bone formation is impaired in a model of type 1 diabetes.

21 January 2018

1 reference

An overview of the regulation of bone remodelling at the cellular level.

21 January 2018

1 reference

Wnt signaling in osteoblasts and bone diseases

21 January 2018

1 reference

Sclerostin: current knowledge and future perspectives

21 January 2018

1 reference

Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism

21 January 2018

1 reference

Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women

21 January 2018

1 reference

Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults

21 January 2018

1 reference

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein

21 January 2018

1 reference

Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength

21 January 2018

1 reference

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.

21 January 2018

1 reference

Wnt/β-catenin signaling and disease

21 January 2018

1 reference

Osteoporosis: now and the future

21 January 2018

1 reference

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation

21 January 2018

1 reference

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

21 January 2018

1 reference

Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease

21 January 2018

1 reference

Sclerostin and bone strength in women in their 10th decade of life

21 January 2018

1 reference

Bone: from a reservoir of minerals to a regulator of energy metabolism

21 January 2018

1 reference

Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus.

21 January 2018

1 reference

Control of bone mass and remodeling by PTH receptor signaling in osteocytes

21 January 2018

1 reference

Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus

21 January 2018

1 reference

21 January 2018

The amazing osteocyte

1 reference

Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study

21 January 2018

1 reference

Serum sclerostin increases in healthy adult men during bed rest.

21 January 2018

1 reference

Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin

21 January 2018

1 reference

Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training

21 January 2018

1 reference

Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEN.12364

1 reference

1 April 2018

1 reference

1 April 2018